Residents with Alzheimer's disease who are taking antipsychotic medications should be watched closely for pneumonia, especially during flu season. Read More »
Will hospitals and nursing homes ever be able to agree on a standard set of data to share during patient transfers? Thought leaders at the annual NASL meeting discuss the current regs—and what needs to happen next. Read More »
New research on how Parkinson’s disease affects brain activity could help measure the effectiveness of future clinical trials and offer insight into new treatments. Read More »
The French pharmaceutical and Verily Life Sciences LLC announced a nearly $500 million joint venture aimed at offering devices and services for people with diabetes, one of the fastest growing disease markets. Read More »
In this segment of our original research series, learn how each resident’s personal story can be used to enhance communication, interaction and care delivery. Read More »
SPONSORED BY:
Adding Medicaid to your mix
By Chris Junker, CEO of Procura Leveraging technology can maximize revenue and diversification of home healthcare service, especially in the complex environment of serving the Medicaid-eligible population. Learn More »
SPONSORED BY:
Advance care planning: Easing the difficult conversation
By Dan Hogan, founder and CEO, Medalogix Discussing and documenting end-of-life choices is a key component of person-centered care, yet advance care planning is something we often put off far longer than we should. Learn More »
Memory and cognition improved in a small study of people with cognitive impairment or Alzheimer’s disease by following a personalized therapeutic approach called metabolic enhancement for neurodegeneration (MEND), a 36-point diet, lifestyle and vitamin regimen. Read More »
The U.S. Food and Drug Administration has issued draft guidance to reduce sodium intake to 2,300 milligrams per day. One in three Americans has high blood pressure, a risk factor for heart disease and stroke. Read More »
Sunrise Senior Living will make a donation to the Alzheimer's Association's Brain Ball in honor of national honoree Thomas J. DeRosa, CEO of Welltower, Inc. Read More »
